MEDraysintell is a team of international experts providing first-rate strategic intelligence in nuclear medicine, radiopharmaceutical, cyclotron, proton therapy and brachytherapy. We offer the most comprehensive set of reports and directories, with over 4,900 pages of unrivaled intelligence covering some of the most exciting healthcare technologies using radiation for diagnosis and treatment. MEDraysintell also offers client-specific intelligence in the field of radiation healthcare, with the upmost knowledge leveraging our extended network of worldwide contacts.
Key figures
While in 2013, MEDraysintell served about 10 clients, we now serve about 200 clients operating in the field of medical radiation, investment banks and institutional investors, large international consulting firms and universities research laboratories.
95% of the revenue is generated outside of Belgium: 40% in Europe, 35% from USA/Canada and 15% from Asia & Middle-East.
Revenues generated from the sales of the Nuclear Medicine Report & Directory has roughly tripled between 2018 to 2021 and continues to growth strongly in 2022.
95% of the revenue is generated outside of Belgium: 40% in Europe, 35% from USA/Canada and 15% from Asia & Middle-East.
Revenues generated from the sales of the Nuclear Medicine Report & Directory has roughly tripled between 2018 to 2021 and continues to growth strongly in 2022.
Contact person: Paul-Emmanuel Goethals, Co-Founder
peg@medraysintell.com
https://www.medraysintell.com/
peg@medraysintell.com
32 491 080 968
MEDraysintell
Activities and description
MEDraysintell is a team of international experts providing first-rate strategic intelligence in nuclear medicine, radiopharmaceutical, cyclotron, proton therapy and brachytherapy.
MEDraysintell was created in 2013 by Paul-Emmanuel Goethals and Richard Zimmermann.
Application fields
We offer the most comprehensive set of reports and directories, with over 4,600 pages of unrivaled intelligence covering some of the most exciting healthcare technologies using radiation for diagnosis and treatment.
- Nuclear Medicine Report & Directory Edition 2022: A set of three reports (nearly 3,500 pages) aiming to provide a comprehensive and exhaustive review of the worldwide nuclear medicine landscape, through a description of about 970 products, together with a comprehensive profile of 380 companies active in nuclear medicine, radiopharmaceutical development production and sale. In addition 3,100 bibliographical references and their Web links.
- Cyclotrons used in Nuclear Medicine Report & Directory, Edition 2020: A 450-page report providing an extensive review of all cyclotrons installed or recently sold in all countries and regions of the world with an exhaustive profile of the companies active in this industry, including an appendix with detailed lists of the 1,484 cyclotrons.
- Proton Therapy World Market Report & Directory Edition 2021: A comprehensive review (380-pages) of the world market dynamics with an analysis of both past evolutions and future trends to the year 2030, and a detailed profile of 36 promoters, manufacturers or developers of proton and carbon therapy equipment with a directory of all PT facilities that are expected to become operational by 2025.
- Brachytherapy Market Report & Directory Edition 2016: A 340-page document providing a complete description of the radionuclides and devices used in brachytherapy, and a detailed profile of 62 companies and institutions active in this field around the world.
Ongoing projects/partnerships/collaborations
MEDraysintell develops a platform of Experts in medical radiation able to answer specific requests in a one stop shopping solutions.